FREENOME HOLDINGS, INC.
Profile
Company Names
FREENOME HOLDINGS, INC.
Addresses
279 E GRAND AVENUE, 5TH FLOOR, SOUTH SAN FRANCISCO, CA 94080
279 E. GRAND AVE., 5TH FLOOR, SOUTH SAN FRANCISCO, CA 94080
259 E GRAND AVENUE, SOUTH SAN FRANCISCO, CA 94080
201 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CA 94080
2401 WALNUT STREET, SUITE 102, PHILADELPHIA, PA 19103
Phone Numbers
(650) 446-6630
(831) 704-6883
Entity Type:
CORPORATION
Industry:
OTHER TECHNOLOGY, OTHER
Year Incorporated:
2016
State Incorporated:
DELAWARE
Total Amount Raised:
$750,550,603.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-11-22
$242,999,843.00
$300,000,000.00
$57,000,157.00
Equity
4
2020-08-14
$269,999,879.00
$269,999,879.00
$0.00
Equity
3
2019-06-24
$159,999,918.00
$159,999,918.00
$0.00
Equity
2
2017-02-23
$71,999,965.00
$71,999,965.00
$0.00
Equity
1
2016-05-23
$5,550,998.00
$5,550,998.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
RILEY
ENNIS
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PETER
KOLCHINSKY
DIRECTOR
RA CAPITAL HEALTHCARE FUND II, L.P.
| RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD
| RA CAPITAL HEALTHCARE FUND LP
| CELLSCAPE CORP
| DICERNA PHARMACEUTICALS INC
| WAVE LIFE SCIENCES PTE LTD
| CALIMMUNE, INC.
| LANTOS TECHNOLOGIES, INC.
| G1 THERAPEUTICS, INC.
| SOJOURNIX, INC.
| ADEO HEALTH SCIENCE, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.
| RA CAPITAL NEXUS FUND, L.P.
| VAXESS TECHNOLOGIES, INC.
| ICOSAVAX, INC.
| ARS PHARMACEUTICALS, INC.
| FREENOME HOLDINGS, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.
| RA CAPITAL NEXUS FUND III, L.P.
| NATURE-S TOOLBOX, INC.
| RA CAPITAL PLANETARY HEALTH FUND, L.P.
| RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.
| TERRESTRIAL BIO, INC.
AMIR
NASHAT
DIRECTOR
PROMEDIOR INC
| AVILA THERAPEUTICS INC
| PERVASIS THERAPEUTICS INC
| FATE THERAPEUTICS INC
| BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| POLARIS VENTURE PARTNERS VI, L.P.
| SUN CATALYTIX CORP
| RECEPTOS, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| POLARIS PARTNERS VII, L.P.
| ATYR PHARMA INC
| AGBIOME, LLC
| METACRINE, INC.
| SCHOLAR ROCK LLC
| 1366 TECHNOLOGIES INC
| SOFREGEN MEDICAL INC.
| POLARIS ENTREPRENEURS- FUND VIII, L.P.
| SYROS PHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| CAMP4 THERAPEUTICS CORP
| MORPHIC HOLDING, LLC
| FREENOME HOLDINGS, INC.
| PRIMMUNE THERAPEUTICS, INC.
| MORPHIC HOLDING, INC.
MICHAEL
NOLAN
EXECUTIVE OFFICER, DIRECTOR
GABRIEL
OTTE
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
VIJAY
PANDE
DIRECTOR
RANDAL
SCOTT
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

